Result Page 12 for Sector: Healthcare Industry: Biotechnology Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
All countries
- {{country.name}}
- All countries
- United States (1011)
- Australia (58)
- Austria (16)
- Belgium (7)
- Brazil (16)
- Canada (83)
- China (94)
- Denmark (6)
- Finland (4)
- France (41)
- Germany (737)
- Hong Kong (46)
- India (19)
- Ireland (1)
- Israel (19)
- Italy (4)
- Japan (37)
- Mexico (28)
- Netherlands (3)
- New Zealand (1)
- Norway (14)
- Poland (9)
- Russia (2)
- South Korea (10)
- Spain (4)
- Sweden (70)
- Switzerland (11)
- Taiwan (67)
- Thailand (2)
- Turkey (1)
- United Kingdom (69)
All exchanges
- {{item.name}}
- All exchanges
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Healthcare (2608)
- {{item.name}}
- All sectors
- Healthcare (2608)
Biotechnology (2608)
- {{item.name}}
- All Industries
- Biotechnology (2608)
- Drug Manufacturers-General (279)
- Drug Manufacturers-Specialty & Generic (1702)
- Healthcare Plans (57)
- Medical Care Facilities (554)
- Pharmaceutical Retailers (155)
- Health Information Services (420)
- Medical Devices (913)
- Medical Instruments & Supplies (502)
- Diagnostics & Research (427)
- Medical Distribution (138)
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Vertex Pharmaceuticals Incorporated VX1.F | $449.65 491.53 USD |
+0.93
|
$116.6B 127.46B USD | $16 17.49 USD | $449.65 491.53 USD | $450.65 492.62 USD | $116.6B 127.46B USD | 31.33 | $14.35 15.69 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $94.59 19.17 USD |
+1.55
|
$625.35B 126.75B USD | $6 1.22 USD | $93.17 18.88 USD | $94.68 19.19 USD | $625.35B 126.75B USD | 31.21 | $3.03 0.61 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $445.8 487.32 USD |
-0.87
|
$115.04B 125.75B USD | $0 0 USD | $445.8 487.32 USD | $450.3 492.24 USD | $115.04B 125.75B USD | 31.26 | $14.26 15.59 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $445.4 486.88 USD |
-1.07
|
$114.94B 125.64B USD | $82 89.64 USD | $442.95 484.2 USD | $450.25 492.18 USD | $114.94B 125.64B USD | 31.01 | $14.36 15.7 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $19,035.51 1127.14 USD |
0
|
$2.11T 124.64B USD | $0 0 USD | $19,035.51 1127.14 USD | $19,035.51 1127.14 USD | $2.11T 124.64B USD | 30.48 | $624.36 36.97 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $973 1063.62 USD |
+0.58
|
$106.97B 116.94B USD | $0 0 USD | $971.8 1062.31 USD | $973 1063.62 USD | $106.97B 116.94B USD | 31.04 | $31.34 34.26 USD | |
| CSL Limited CSJA.F | $88 96.2 USD |
+0.57
|
$86.79B 94.87B USD | $8 8.75 USD | $88 96.2 USD | $88 96.2 USD | $86.79B 94.87B USD | 37.13 | $2.37 2.59 USD | |
| CSL CMXHF | $192 — |
0
|
$94.38B — | $80 — | $192 — | $192 — | $94.38B — | 37.72 | $5.09 — | |
| CSL Limited CSJ.F | $176.44 192.87 USD |
-0.53
|
$85.84B 93.83B USD | $2 2.19 USD | $176.44 192.87 USD | $176.44 192.87 USD | $85.84B 93.83B USD | 37.22 | $4.74 5.18 USD | |
| Moderna, Inc. M1RN34.SA | $37.61 7.62 USD |
+0.99
|
$290.75B 58.93B USD | $5.51K 1.12K USD | $36.77 7.45 USD | $37.84 7.67 USD | $290.75B 58.93B USD | 0 | -$4.19 -0.8 USD | |
| Moderna, Inc. MRNA.MX | $2,574.74 152.46 USD |
+0.3
|
$992.09B 58.74B USD | $892 52.82 USD | $2,500.03 148.03 USD | $2,584 153 USD | $992.09B 58.74B USD | 0 | -$287.5 -17.02 USD | |
| Moderna, Inc. 0QF.MU | $131.16 143.38 USD |
-2.95
|
$50.27B 54.95B USD | $12 13.12 USD | $131.16 143.38 USD | $131.16 143.38 USD | $50.27B 54.95B USD | 0 | -$14.52 -15.8 USD | |
| Moderna, Inc. MRNA.VI | $128.2 140.14 USD |
-2.85
|
$49.13B 53.71B USD | $797 871.23 USD | $127.16 139 USD | $131.5 143.75 USD | $49.13B 53.71B USD | 0 | -$14.41 -15.7 USD | |
| Moderna, Inc. 0QF.F | $126.8 138.61 USD |
-2.61
|
$48.67B 53.2B USD | $216 236.12 USD | $126.8 138.61 USD | $131.38 143.62 USD | $48.67B 53.2B USD | 0 | -$14.52 -15.8 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $736,000 555.56 USD |
-0.14
|
$52.38T 39.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $52.38T 39.54B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $6 6.56 USD | $227.2 248.36 USD | $227.2 248.36 USD | $27.27B 29.81B USD | 0 | -$7.12 -7.7 USD | |
| UCB SA UNC.F | $137.85 150.69 USD |
+1.03
|
$26.43B 28.89B USD | $70 76.52 USD | $137.35 150.14 USD | $138.45 151.34 USD | $26.43B 28.89B USD | 78.32 | $1.76 1.92 USD | |
| UCB SA UCB.VI | $136.9 149.65 USD |
+0.88
|
$26.39B 28.85B USD | $67 73.24 USD | $136.4 149.1 USD | $136.9 149.65 USD | $26.39B 28.85B USD | 77.78 | $1.76 1.92 USD | |
| UCB SA UNC0.F | $68 74.33 USD |
+0.74
|
$26.35B 28.81B USD | $4 4.37 USD | $68 74.33 USD | $68 74.33 USD | $26.35B 28.81B USD | 77.27 | $0.88 0.96 USD | |
| Celltrion, Inc. 068270.KS | $179,800 135.72 USD |
-1.96
|
$37.31T 28.17B USD | $0 0 USD | $0 0 USD | $0 0 USD | $37.31T 28.17B USD | 0 | $0 0 USD | |
| UCB SA UCBJF | $132.5 — |
0
|
$28B — | $623 — | $132 — | $132.5 — | $28B — | 69.73 | $1.9 — | |
| argenx SE A1RG34.SA | $82.96 16.81 USD |
-0.16
|
$123.36B 25B USD | $5 1.01 USD | $82.96 16.81 USD | $82.96 16.81 USD | $123.36B 25B USD | 0 | -$30.47 -6.1 USD | |
| BioNTech SE 0A3M.IL | $88.85 — |
-4.9
|
$24.44B — | $8.16K — | $87.48 — | $92.39 — | $24.44B — | 4.93 | $18 — | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $77 84.17 USD | $331 361.83 USD | $331 361.83 USD | $21.66B 23.68B USD | 68.12 | $4.86 5.31 USD | |
| argenx SE ARGX.VI | $360.8 394.4 USD |
+0.53
|
$21.56B 23.57B USD | $0 0 USD | $360.8 394.4 USD | $360.8 394.4 USD | $21.56B 23.57B USD | 0 | -$5.24 -5.7 USD | |
| argenx SE 1AEA.F | $358 391.34 USD |
0
|
$21.45B 23.45B USD | $19 20.77 USD | $358 391.34 USD | $358 391.34 USD | $21.45B 23.45B USD | 0 | -$5.3 -5.7 USD | |
| argenx SE 1AE.F | $358.6 392 USD |
-1.21
|
$21.31B 23.3B USD | $10 10.93 USD | $358.6 392 USD | $358.6 392 USD | $21.31B 23.3B USD | 0 | -$5.3 -5.7 USD | |
| BioNTech SE B1NT34.SA | $29.77 6.03 USD |
-3.78
|
$114.79B 23.27B USD | $279 56.55 USD | $29.5 5.98 USD | $30.79 6.24 USD | $114.79B 23.27B USD | 175.11 | $0.17 0.03 USD | |
| argenx SE ARGNF | $373.5 — |
0
|
$23.04B — | $1K — | $373.5 — | $373.5 — | $23.04B — | 0 | -$5.68 — | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $44.19 8.96 USD |
+2.91
|
$112.01B 22.7B USD | $13 2.63 USD | $44.19 8.96 USD | $44.62 9.04 USD | $112.01B 22.7B USD | 0 | -$0.71 -0.1 USD | |
| BioNTech SE 22UA.F | $83.4 91.17 USD |
-3.92
|
$20.1B 21.97B USD | $977 1.07K USD | $81.15 88.71 USD | $87.55 95.7 USD | $20.1B 21.97B USD | 177.44 | $0.47 0.51 USD | |
| BioNTech SE BNTX.VI | $82.7 90.4 USD |
-5.27
|
$19.93B 21.79B USD | $10 10.93 USD | $82.7 90.4 USD | $87.2 95.32 USD | $19.93B 21.79B USD | 175.95 | $0.47 0.51 USD | |
| Genmab A/S 0MGB.IL | $1,806.5 264.87 USD |
-1.15
|
$144.67B 21.21B USD | $64.09K 9.4K USD | $1,790.5 262.53 USD | $1,827.5 267.95 USD | $144.67B 21.21B USD | 25.52 | $70.77 10.38 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $148.8 162.66 USD |
+0.47
|
$18.98B 20.75B USD | $50 54.66 USD | $148.8 162.66 USD | $148.8 162.66 USD | $18.98B 20.75B USD | 0 | -$2.46 -2.6 USD | |
| BeiGene, Ltd. B1GN34.SA | $35.8 7.26 USD |
0
|
$95.96B 19.45B USD | $0 0 USD | $35.8 7.26 USD | $35.8 7.26 USD | $95.96B 19.45B USD | 0 | -$3.11 -0.6 USD | |
| BeiGene, Ltd. 49BA.F | $149 162.88 USD |
-1.32
|
$16.9B 18.47B USD | $40 43.73 USD | $149 162.88 USD | $149 162.88 USD | $16.9B 18.47B USD | 0 | -$7.02 -7.6 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $231 46.82 USD |
+2.87
|
$87.72B 17.78B USD | $200 40.54 USD | $231 46.82 USD | $231 46.82 USD | $87.72B 17.78B USD | 81.05 | $2.85 0.58 USD | |
| BeiGene, Ltd. 49B.F | $11.3 12.35 USD |
-2.59
|
$16.23B 17.74B USD | $12 13.12 USD | $11.3 12.35 USD | $11.3 12.35 USD | $16.23B 17.74B USD | 0 | -$0.54 -0.5 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,565 92.67 USD |
0
|
$297.16B 17.6B USD | $0 0 USD | $1,565 92.67 USD | $1,565 92.67 USD | $297.16B 17.6B USD | 80.01 | $19.56 1.16 USD | |
| Genmab A/S GNMSF | $260 — |
0
|
$17.04B — | $20 — | $260 — | $260 — | $17.04B — | 21.59 | $12.04 — | |
| Genmab A/S GMAB.VI | $241 263.45 USD |
-2.03
|
$15.48B 16.92B USD | $0 0 USD | $241 263.45 USD | $245.4 268.26 USD | $15.48B 16.92B USD | 21.67 | $11.12 12.16 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $23 25.14 USD | $80.76 88.28 USD | $81.08 88.63 USD | $15.26B 16.68B USD | 115.74 | $0.7 0.77 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $79.18 86.55 USD |
+0.97
|
$15.03B 16.43B USD | $0 0 USD | $78.14 85.42 USD | $79.18 86.55 USD | $15.03B 16.43B USD | 80.79 | $0.98 1.07 USD | |
| Royalty Pharma plc RPD.MU | $25.4 27.77 USD |
-0.39
|
$14.92B 16.31B USD | $75 81.99 USD | $25.4 27.77 USD | $25.4 27.77 USD | $14.92B 16.31B USD | 15.30 | $1.66 1.81 USD | |
| Royalty Pharma plc RPD.F | $24.77 27.08 USD |
-0.56
|
$14.89B 16.28B USD | $2K 2.19K USD | $24.77 27.08 USD | $25.02 27.35 USD | $14.89B 16.28B USD | 14.92 | $1.66 1.81 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $77.8 85.05 USD |
-0.77
|
$14.77B 16.15B USD | $85 92.92 USD | $77.8 85.05 USD | $77.82 85.07 USD | $14.77B 16.15B USD | 78.58 | $0.99 1.08 USD | |
| Incyte Corporation I1NC34.SA | $167.5 33.95 USD |
0
|
$65.99B 13.38B USD | $0 0 USD | $167.5 33.95 USD | $167.5 33.95 USD | $65.99B 13.38B USD | 18.94 | $8.84 1.79 USD | |
| Incyte Corporation INCY.MX | $1,096.52 64.93 USD |
0
|
$225.5B 13.35B USD | $0 0 USD | $1,096.52 64.93 USD | $1,096.52 64.93 USD | $225.5B 13.35B USD | 18.01 | $60.86 3.6 USD | |
| Bio-Techne Corporation T1CH34.SA | $13.62 2.76 USD |
-1.52
|
$64.39B 13.05B USD | $1 0.2 USD | $13.62 2.76 USD | $13.62 2.76 USD | $64.39B 13.05B USD | 61.90 | $0.22 0.04 USD | |
| United Therapeutics Corporation UTH.F | $267.5 292.41 USD |
+0.26
|
$11.93B 13.04B USD | $50 54.66 USD | $267.5 292.41 USD | $267.5 292.41 USD | $11.93B 13.04B USD | 13.60 | $19.66 21.49 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Incyte Corporation ICY.F | $57.94 63.34 USD |
-0.65
|
$11.41B 12.48B USD | $236 257.98 USD | $57.94 63.34 USD | $57.94 63.34 USD | $11.41B 12.48B USD | 18.87 | $3.07 3.36 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $32.46 6.58 USD |
-1.58
|
$61.36B 12.44B USD | $50 10.13 USD | $32.46 6.58 USD | $32.46 6.58 USD | $61.36B 12.44B USD | 270.50 | $0.12 0.02 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Bio-Techne Corporation TE1.F | $71 77.61 USD |
+0.71
|
$11.21B 12.26B USD | $2 2.19 USD | $71 77.61 USD | $71 77.61 USD | $11.21B 12.26B USD | 61.20 | $1.16 1.27 USD | |
| Bio-Techne Corporation TECH.MX | $1,310.32 77.59 USD |
-2.54
|
$206.49B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $206.49B 12.23B USD | 51.58 | $25.4 1.5 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $114.3 124.95 USD |
-1.42
|
$10.8B 11.81B USD | $900 983.82 USD | $114.3 124.95 USD | $114.3 124.95 USD | $10.8B 11.81B USD | 278.78 | $0.41 0.45 USD | |
| Insmed Incorporated IM8N.F | $59.5 65.04 USD |
+4.39
|
$10.14B 11.08B USD | $74 80.89 USD | $59.5 65.04 USD | $59.5 65.04 USD | $10.14B 11.08B USD | 0 | -$4.87 -5.3 USD | |
| Insmed Incorporated IM8N.SG | $59.5 65.04 USD |
+1.71
|
$9.88B 10.8B USD | $0 0 USD | $57 62.31 USD | $58.5 63.95 USD | $9.88B 10.8B USD | 0 | -$4.87 -5.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Vaxcyte, Inc. 5VA.MU | $68.5 74.88 USD |
-0.72
|
$7.45B 8.15B USD | $10 10.93 USD | $68.5 74.88 USD | $68.5 74.88 USD | $7.45B 8.15B USD | 0 | -$4 -4.3 USD | |
| Vaxcyte, Inc. 5VA.F | $68 74.33 USD |
-1.45
|
$7.4B 8.09B USD | $4 4.37 USD | $68 74.33 USD | $68 74.33 USD | $7.4B 8.09B USD | 0 | -$4 -4.3 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.34 4.74 USD |
-0.91
|
$7.34B 8.02B USD | $130 142.11 USD | $4.34 4.74 USD | $4.52 4.94 USD | $7.34B 8.02B USD | 0 | -$0.09 -0.09 USD | |
| Roivant Sciences Ltd. 87S.F | $9.52 10.4 USD |
-0.29
|
$7.33B 8.02B USD | $500 546.57 USD | $9.52 10.4 USD | $9.54 10.43 USD | $7.33B 8.02B USD | 1.95 | $4.87 5.32 USD | |
| Innovent Biologics IVBXF | $4.88 — |
0
|
$7.91B — | $100 — | $4.88 — | $4.88 — | $7.91B — | 0 | -$0.09 — | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.37B 7.78B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.37B 7.78B USD | 0 | -$42.65 -2.5 USD | |
| Legend Biotech Corporation 9LB.F | $39 42.63 USD |
-1.52
|
$7.11B 7.77B USD | $50 54.66 USD | $38.2 41.76 USD | $39.4 43.07 USD | $7.11B 7.77B USD | 0 | -$2.4 -2.6 USD | |
| Ascendis Pharma A/S A1SN34.SA | $45.1 9.14 USD |
-4.25
|
$37.45B 7.59B USD | $5 1.01 USD | $45.1 9.14 USD | $45.1 9.14 USD | $37.45B 7.59B USD | 0 | -$51.1 -10.3 USD | |
| Ascendis Pharma A/S A71.F | $119 130.08 USD |
0
|
$6.8B 7.43B USD | $1K 1.09K USD | $119 130.08 USD | $119 130.08 USD | $6.8B 7.43B USD | 0 | -$8.87 -9.6 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $105.45 115.27 USD |
+0.48
|
$6.66B 7.28B USD | $10 10.93 USD | $104.75 114.51 USD | $105.45 115.27 USD | $6.66B 7.28B USD | 23.43 | $4.5 4.92 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.33 0.36 USD |
+4.25
|
$6.45B 7.05B USD | $8.85K 9.67K USD | $0.32 0.35 USD | $0.33 0.36 USD | $6.45B 7.05B USD | 33.38 | $0.01 0.01 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.3699 — |
+16.05
|
$6.87B — | $1.89K — | $0.3699 — | $0.3699 — | $6.87B — | 36.54 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $7.2 — |
-2.83
|
$6.76B — | $1.25K — | $7.2 — | $7.2 — | $6.76B — | 24.82 | $0.29 — | |
| Blueprint Medicines Corporation 2L9.F | $97.92 107.04 USD |
-1.57
|
$6.13B 6.7B USD | $55 60.12 USD | $97.92 107.04 USD | $100.5 109.86 USD | $6.13B 6.7B USD | 0 | -$4.49 -4.9 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $2.76 3.02 USD |
+2.22
|
$5.94B 6.49B USD | $1.05K 1.14K USD | $2.76 3.02 USD | $2.76 3.02 USD | $5.94B 6.49B USD | 13.80 | $0.2 0.22 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.41 1.55 USD |
+1.89
|
$5.92B 6.47B USD | $5.33K 5.82K USD | $1.41 1.55 USD | $1.41 1.55 USD | $5.92B 6.47B USD | 14.13 | $0.1 0.11 USD | |
| Revolution Medicines, Inc. 42Z.F | $35.8 39.13 USD |
-2.72
|
$5.91B 6.46B USD | $25 27.33 USD | $35.8 39.13 USD | $36 39.35 USD | $5.91B 6.46B USD | 0 | -$3.58 -3.9 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.14 50.44 USD |
+0.13
|
$5.87B 6.42B USD | $85 92.92 USD | $46.14 50.44 USD | $46.14 50.44 USD | $5.87B 6.42B USD | 20.59 | $2.24 2.45 USD | |
| Cytokinetics, Incorporated KK3A.F | $49.8 54.44 USD |
-0.4
|
$5.86B 6.41B USD | $80 87.45 USD | $49.8 54.44 USD | $49.8 54.44 USD | $5.86B 6.41B USD | 0 | -$5.03 -5.4 USD | |
| Exelixis, Inc. EX9.F | $20.11 21.98 USD |
-0.79
|
$5.86B 6.4B USD | $180 196.76 USD | $20.11 21.98 USD | $20.11 21.98 USD | $5.86B 6.4B USD | 32.96 | $0.61 0.67 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $261.9 286.29 USD |
+1.55
|
$5.59B 6.12B USD | $35 38.26 USD | $255.4 279.19 USD | $261.9 286.29 USD | $5.59B 6.12B USD | 0 | -$21.55 -23.5 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $37.85 41.38 USD |
-0.86
|
$5.52B 6.04B USD | $27 29.51 USD | $37.85 41.38 USD | $37.85 41.38 USD | $5.52B 6.04B USD | 0 | -$2.49 -2.7 USD | |
| Viking Therapeutics, Inc. 1VT.F | $47.57 52 USD |
+1.84
|
$5.44B 5.94B USD | $717 783.78 USD | $47.48 51.9 USD | $48.74 53.28 USD | $5.44B 5.94B USD | 0 | -$0.85 -0.9 USD | |
| Zealand Pharma A/S ZLDPF | $92.46 — |
0
|
$5.94B — | $1K — | $92.46 — | $92.46 — | $5.94B — | 0 | -$1.79 — | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| BridgeBio Pharma, Inc. 2CL.F | $25.81 28.21 USD |
-1.49
|
$4.83B 5.28B USD | $200 218.63 USD | $25.8 28.2 USD | $25.81 28.21 USD | $4.83B 5.28B USD | 0 | -$3.01 -3.2 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Financière de Tubize SA FTD.SG | $106.4 116.31 USD |
0
|
$4.75B 5.2B USD | $0 0 USD | $106.4 116.31 USD | $106.4 116.31 USD | $4.75B 5.2B USD | 53.73 | $1.98 2.16 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $38.97 42.59 USD |
+0.05
|
$4.75B 5.19B USD | $20 21.86 USD | $38.55 42.14 USD | $38.97 42.59 USD | $4.75B 5.19B USD | 0 | -$3.19 -3.4 USD | |
| Financière de Tubize SA FTD.F | $105.8 115.65 USD |
-0.75
|
$4.72B 5.16B USD | $35 38.26 USD | $105.8 115.65 USD | $105.8 115.65 USD | $4.72B 5.16B USD | 53.43 | $1.98 2.16 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$86.55B 5.12B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $86.55B 5.12B USD | 21.27 | $31.96 1.89 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Krystal Biotech, Inc. 4KB.F | $163.3 178.51 USD |
-3.52
|
$4.66B 5.1B USD | $3 3.28 USD | $162.05 177.14 USD | $165.15 180.53 USD | $4.66B 5.1B USD | 80.44 | $2.03 2.22 USD | |
|
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
||||||||||